Nipple aspirate fluid expression of urokinase-type plasminogen activator, plasminogen activator inhibitor-1, and urokinase-type plasminogen activator receptor predicts breast cancer diagnosis and advanced disease.

MLA

Qin, Wenyi, et al. “Nipple Aspirate Fluid Expression of Urokinase-Type Plasminogen Activator, Plasminogen Activator Inhibitor-1, and Urokinase-Type Plasminogen Activator Receptor Predicts Breast Cancer Diagnosis and Advanced Disease.” Annals of Surgical Oncology, vol. 10, no. 8, Oct. 2003, pp. 948–53. EBSCOhost, https://doi.org/10.1245/aso.2003.03.518.

APA

Qin, W., Zhu, W., Wagner-Mann, C., & Sauter, E. R. (2003). Nipple aspirate fluid expression of urokinase-type plasminogen activator, plasminogen activator inhibitor-1, and urokinase-type plasminogen activator receptor predicts breast cancer diagnosis and advanced disease. Annals of Surgical Oncology, 10(8), 948–953. https://doi.org/10.1245/aso.2003.03.518

Chicago

Qin, Wenyi, Weizhu Zhu, Colette Wagner-Mann, and Edward R Sauter. 2003. “Nipple Aspirate Fluid Expression of Urokinase-Type Plasminogen Activator, Plasminogen Activator Inhibitor-1, and Urokinase-Type Plasminogen Activator Receptor Predicts Breast Cancer Diagnosis and Advanced Disease.” Annals of Surgical Oncology 10 (8): 948–53. doi:10.1245/aso.2003.03.518.